← Back to Search

Behavioral Intervention

Mobile App Intervention for Suicide Prevention

N/A

Waitlist Available

Led By José A Bauermeister, PhD, MPH

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Is aged 18-24 years (inclusive)

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to 6 months

Awards & highlights

Study Summary

This trial will test a mobile application designed to reduce suicide risk for sexual minorities going through the transition to adulthood. The app will provide skills coaching and peer mentoring, and will be tested with a racially diverse group of people who have suicidal ideation.

Who is the study for?

This trial is for emerging adult sexual minorities aged 18-24 in the Philadelphia area who have experienced suicidal thoughts in the past month. Participants must use a smartphone daily and not plan to move away soon. Those with unmanaged psychotic disorders or without recent suicidal ideation are excluded.Check my eligibility

What is being tested?

The STARS program, which includes skills coaching and peer mentoring via a mobile app, is being tested against a control condition involving safety planning protocol. The goal is to see if STARS can reduce suicide risk among young adults who identify as sexual minorities.See study design

What are the potential side effects?

Since this intervention involves psychological support rather than medication, typical drug side effects aren't expected. However, discussing sensitive topics like suicide may cause emotional discomfort or distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 24 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Suicidal Ideation and Behavior

Secondary outcome measures

Social Support

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: STARSExperimental Treatment1 Intervention

The investigators will deliver an online intervention focused on safety planning (STARS). The intervention content includes life skills interactive modules across 14 domains, a goal tracker, referral to community resources, and scheduling of peer mentoring sessions.

Group II: Control ConditionActive Control1 Intervention

The investigators will deliver an in-person therapeutic session where participants can develop an individualized safety plan for use during a suicidal crisis, focusing on adaptive coping, addressing barriers or ambivalence, and strengthening their self-efficacy.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

STARS

2013

N/A

~30

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,000 Previous Clinical Trials

42,880,024 Total Patients Enrolled

16 Trials studying Suicide

57,449 Patients Enrolled for Suicide

National Institute of Mental Health (NIMH)NIH

2,783 Previous Clinical Trials

2,689,085 Total Patients Enrolled

112 Trials studying Suicide

1,156,755 Patients Enrolled for Suicide

José A Bauermeister, PhD, MPHPrincipal InvestigatorUniversity of Pennsylvania

1 Previous Clinical Trials

217 Total Patients Enrolled

Media Library

STARS (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05018143 — N/A

Suicide Research Study Groups: STARS, Control Condition

Suicide Clinical Trial 2023: STARS Highlights & Side Effects. Trial Name: NCT05018143 — N/A

STARS (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05018143 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment criteria of this experiment permitting people aged 25 and over to participate?

"Subjects aged 18 to 24 years old are welcome to partake in this clinical trial."

Answered by AI

How many individuals will be admitted to this experiment?

"Affirmative, the information located on clinicaltrials.gov confirms that this research study is currently recruiting participants. First posted on October 20th 2022 and most recently updated on December 4th 2022, 60 individuals are needed at one medical center to take part in this trial."

Answered by AI

Am I eligible to sign up for this medical experiment?

"Patients considering joining this clinical trial should be of suicidal disposition and aged between 18-24. Around 60 individuals are being accepted into the study."

Answered by AI

Are there still opportunities for individuals to join this medical experiment?

"Affirmative, clinicaltrials.gov suggests that patient recruitment for this trial is in progress. It was initially posted on October 20th 2022 and the last update occurred on December 4th 2022. The study is looking to enroll 60 patients from 1 medical site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Suicide Prevention Intervention for Vulnerable Emerging Adult Sexual Minorities

Jose Bauermeister 2022. "Suicide Prevention Intervention for Vulnerable Emerging Adult Sexual Minorities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05018143.